Thema
Journal Article
677
SARS-CoV-2
335
Protease Inhibitors
262
COVID-19
257
Research Support, Non-U.S. Gov't
229
Antiviral Agents
196
molecular docking
191
molecular dynamics
113
Spike Glycoprotein, Coronavirus
107
spike protein, SARS-CoV-2
102
EC 3.4.-
100
Peptide Hydrolases
98
EC 3.4.22.-
88
molecular dynamics simulation
73
3C-like proteinase, SARS-CoV-2
71
Coronavirus 3C Proteases
70
EC 3.4.22.28
70
MD simulation
61
EC 3.4.17.23
59
Angiotensin-Converting Enzyme 2
58
docking
57
main protease
55
virtual screening
51
RNA, Viral
41
EC 2.7.7.48
39
Ligands
37
Pharmaceutical Preparations
36
Phytochemicals
36
RNA-Dependent RNA Polymerase
36
drug repurposing
36
Coronavirus
33
ACE2
28
Viral Nonstructural Proteins
28
ADMET
27
molecular dynamics simulations
26
spike protein
26
COVID-19 Vaccines
25
Covid-19
24
Cysteine Endopeptidases
22
EC 3.4.22.2
21
Epitopes, B-Lymphocyte
21
Epitopes, T-Lymphocyte
21
RdRp
21
Mpro
20
binding free energy
20
3CLpro
19
Papain
18
molecular dynamic simulation
18
spike glycoprotein
18
Biological Products
17
mehr ...